首页/数据集/Association between influence factors and frequent ADEs in etanercept.

Association between influence factors and frequent ADEs in etanercept.

Figshare2018-11-09 更新2026-04-29 收录

数据链接：

https://figshare.com/articles/dataset/Association_between_influence_factors_and_frequent_ADEs_in_etanercept_/7322681 数据链接链接失效反馈

官方服务：

资源简介：

Association between influence factors and frequent ADEs in etanercept.

应用场景：

创建时间：

2018-11-09

用药安全

不良事件分析

Ospemifene has been authorized for the treatment of vulvovaginal atrophy (VVA). This study wasto evaluate adverse events (AEs) associated with ospemifene by data mining the US Food and Drug Administra

DataCite Commons2024-02-27 更新130

Additional file 4 of Decitabine in combination with fludarabine and cyclophosphamide as a lymphodepletion regimen followed by CD19/CD22 bispecific targeted CAR T-cell therapy significantly improves survival in relapsed/refractory B-ALL patients

肿瘤治疗安全性

不良事件分析

Additional file 4. Adverse Events.

DataCite Commons2024-02-08 更新80

Baseline characteristics of the patients with and without adverse events.

心血管疾病

不良事件分析

ADMA = asymmetric dimethylarginine; AF = atrial fibrillation; CAD = coronary artery disease; LVEF = left ventricular ejection fraction; PCI = percutaneous coronary intervention; TIA = tran

NIAID Data Ecosystem60

Adverse events in patients taking macrolide antibiotics versus placebo for any indication: Supplementary data set B

用药安全

不良事件分析

Supplementary data B Any reported adverse event that occurred in less than 5% of any group – grouped under the primary System Organ Class, according to the MedDRA coding system.

Research Data Australia80

Mean odds ratio (95% CrI) of AEs and discontinuation due to AEs.

药物安全性评估

不良事件分析

*Significant comparisons are in bold with an asterisk. Mean odds ratio (95% CrI) of AEs and discontinuation due to AEs.

NIAID Data Ecosystem70